Approval · Notice of Compliance 28510 · 2022
PROLEUKIN: Notice of Compliance 28510
Issued June 22, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28510
- Date
- June 22, 2022
- Company
- Sterimax Inc.Oakville, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROLEUKIN | Not yet assigned | — |
Medicinal ingredients
- ALDESLEUKIN 22,000,000 UNIT per VIAL